EZZ Life Science Sees AU$19 Million in Cash by End of Q4

EZZ Life Science Holdings (ASX:EZZ) expects to have about AU$19 million in cash by the end of the fourth quarter of its financial year 2024, according to a Thursday Australian bourse filing. The discl

MT NewswiresJun 26 20:03 ET

EZZ Life Science Targets US Expansion

EZZ Life Science Holdings (ASX:EZZ) has set its sights on the lucrative US market after securing regulatory clearance from the United States Food and Drug Administration (FDA) for nine of its products

sharecafeJun 24 22:23 ET

EZZ Life Science Eyes US Market Expansion After Receiving FDA Approval for Nine Products

EZZ Life Science Holdings (ASX: EZZ) has received approval for nine of its products in the food category from the US Food and Drug Administration (FDA).

Small CapsJun 24 21:22 ET

Stocks of the Hour: Telix Pharmaceuticals, AVITA Medical, EZZ Life Science

To register for today's webinar click here.Telix Pharmaceuticals (ASX:TLX) announces additional positive data from the ProstACT SELECT trial of TLX591. TLX591 is an investigational anti-PSMA1 radio-an

sharecafeMay 30 21:50 ET

Is EZZ Life Science Holdings Limited's (ASX:EZZ) Recent Stock Performance Tethered To Its Strong Fundamentals?

Yahoo FinanceMay 27 18:20 ET

EZZ Life's Receipts From Customers Up 111% in Fiscal Q3

EZZ Life Science Holdings (ASX:EZZ) recorded receipts from customers totaling AU$23.6 million in the third quarter of fiscal 2024, a 111% increase on the year-ago period, according to a Wednesday fili

MT NewswiresApr 25 18:25 ET